Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamas Shisha

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Parameters for defining efficacy in fracture healingTamas Shisha
Archives of Orthopaedic and Trauma Surgery|February 19, 2013
Multilingual cross-cultural adaptation of the patient-rated wrist evaluation (PRWE) into Czech, French, Hungarian, Italian, Portuguese (Brazil), Russian and UkrainianJörg Goldhahn, Tamas Shisha, Joy C Macdermid, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 1, 2005
Osteochondritis (Calvé's disease) of a vertebral body--a rare form of vertebra planaTamas Shisha, Sandor Kiss, Peter Pal Varga, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 2, 2023
First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy AdultsTamas Shisha, Maximilian G Posch, Jeanette Lehmann, et al.
Rheumatology (Oxford, England)|July 24, 2020
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trialJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Cell Reports. Medicine|May 17, 2023
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapyStuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Parameters for defining efficacy in fracture healingTamas Shisha
Archives of Orthopaedic and Trauma Surgery|February 19, 2013
Multilingual cross-cultural adaptation of the patient-rated wrist evaluation (PRWE) into Czech, French, Hungarian, Italian, Portuguese (Brazil), Russian and UkrainianJörg Goldhahn, Tamas Shisha, Joy C Macdermid, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 1, 2005
Osteochondritis (Calvé's disease) of a vertebral body--a rare form of vertebra planaTamas Shisha, Sandor Kiss, Peter Pal Varga, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 2, 2023
First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy AdultsTamas Shisha, Maximilian G Posch, Jeanette Lehmann, et al.
Rheumatology (Oxford, England)|July 24, 2020
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trialJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Cell Reports. Medicine|May 17, 2023
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapyStuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Pageof 1